Specifically, the knockdown of ERα in the epithelial and low invasive MCF-7 breast cancer cells leads to EMT and increases the aggressiveness of these cells (MCF-7/SP10+) that exhibit a significantly modified matrix expression pattern and different functional properties, i.e. higher migratory and invasive potential5. The gene discussed is ESR1; the disease is breast cancer.